Retour
Fourchette du Jour
12,63 €
13,18 €
Fourchette 52 Semaines
5,90 €
28,25 €
Volume
3 336 008
Moyenne 50J / 200J
12,99 €
/
12,58 €
Clôture Précédente
13,11 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -3,7 | 0,3 |
| P/B | 2,3 | 2,9 |
| ROE % | -53,5 | 3,7 |
| Net Margin % | -609,9 | 3,8 |
| Rev Growth 5Y % | 19,6 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
19,38 €
+51.3%
Low: 7,00 €
High: 48,00 €
BPA Prévisionnel
-3,62 €
CA Est.
59 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
8,76 €
-1,79 € – 99,21 €
|
2,5 B | 5 |
| FY2029 |
3,86 €
-0,79 € – 43,72 €
|
1,6 B | 10 |
| FY2028 |
-0,69 €
-3,57 € – 15,82 €
|
670 M | 12 |
Points Clés
Revenue grew 19,62% annually over 5 years — strong growth
Debt/Equity of 0,14 — conservative balance sheet
Negative free cash flow of -354,66M
PEG of 0,09 suggests growth is underpriced
Capital efficient — spends only 8,54% of revenue on capex
Croissance
Revenue Growth (5Y)
19,62%
Revenue (1Y)16,92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-53,48%
ROIC-43,25%
Net Margin-609,85%
Op. Margin-651,67%
Sécurité
Debt / Equity
0,14
Current Ratio5,08
Interest Coverage0,00
Valorisation
P/E Ratio
-3,67
P/B Ratio2,25
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,92% | Revenue Growth (3Y) | 36,58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19,62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 67,67M | Net Income (TTM) | -412,69M |
| ROE | -53,48% | ROA | -49,01% |
| Gross Margin | 76,47% | Operating Margin | -651,67% |
| Net Margin | -609,85% | Free Cash Flow (TTM) | -354,66M |
| ROIC | -43,25% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,14 | Current Ratio | 5,08 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -3,67 | P/B Ratio | 2,25 |
| P/S Ratio | 22,36 | PEG Ratio | 0,09 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,51B | Enterprise Value | 1,45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 67,67M | 57,88M | 36,28M | 52,12M | 33,05M |
| Net Income | -412,69M | -519,02M | -481,19M | -474,19M | -267,89M |
| EPS (Diluted) | -3,81 | -5,25 | -5,42 | -6,16 | -3,78 |
| Gross Profit | 51,75M | 47,59M | 27,30M | 44,55M | 26,16M |
| Operating Income | -440,99M | -534,26M | -515,29M | -458,16M | -267,85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 842,13M | 1,19B | 1,30B | 1,52B | 1,29B |
| Total Liabilities | 170,73M | 319,06M | 250,81M | 284,53M | 254,22M |
| Shareholders' Equity | 671,39M | 871,96M | 1,05B | 1,24B | 1,04B |
| Total Debt | 93,33M | 210,20M | 115,35M | 130,70M | 74,02M |
| Cash & Equivalents | 155,46M | 189,18M | 226,75M | 523,51M | 123,41M |
| Current Assets | 527,71M | 639,86M | 998,33M | 1,22B | 769,30M |
| Current Liabilities | 103,88M | 110,85M | 115,21M | 126,55M | 125,83M |